Literature DB >> 24954994

Modification of Microbial Polymalic Acid With Hydrophobic Amino Acids for Drug-Releasing Nanoparticles.

Alberto Lanz-Landázuri1, Montserrat García-Alvarez1, José Portilla-Arias2, Antxon Martínez de Ilarduya1, Eggehard Holler2, Julia Ljubimova2, Sebastián Muñoz-Guerra1.   

Abstract

Microbial poly(β, l-malic acid) was modified with either l-leucine ethyl ester (L) or l-phenylalanine methyl ester (F) to produce amphiphylic copolymers. The degradation of these copolymers in aqueous buffer took place under physiological conditions in a few weeks by hydrolysis of the side chain ester group followed by cleavage of the main chain. Spherical nanoparticles with diameters ranging between 70 and 230 nm were prepared from these copolymers by the dialysis-precipitation method. No alteration of the cell viability was observed after incubation of these nanoparticles in different cell lines. Anticancer drugs temozolomide and doxorubicin were encapsulated in the nanoparticles. Temozolomide was released within several hours whereas doxorubicin took several weeks to be completely liberated.

Entities:  

Keywords:  anticancer; biodegradable nanoparticles; drug delivery system; poly(malic acid); polymalates

Year:  2012        PMID: 24954994      PMCID: PMC4063452          DOI: 10.1002/macp.201200134

Source DB:  PubMed          Journal:  Macromol Chem Phys        ISSN: 1022-1352            Impact factor:   2.527


  17 in total

1.  Hydrolytic and enzymatic degradation of nanoparticles based on amphiphilic poly(gamma-glutamic acid)-graft-L-phenylalanine copolymers.

Authors:  Takami Akagi; Mariko Higashi; Tatsuo Kaneko; Toshiyuki Kida; Mitsuru Akashi
Journal:  Biomacromolecules       Date:  2006-01       Impact factor: 6.988

2.  Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid).

Authors:  Rameshwar Patil; José Portilla-Arias; Hui Ding; Satoshi Inoue; Bindu Konda; Jinwei Hu; Kolja A Wawrowsky; Paul K Shin; Keith L Black; Eggehard Holler; Julia Y Ljubimova
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

3.  Effects of complexation between liposome and poly(malic acid) on aggregation and leakage behaviour.

Authors:  S Osanai; K Nakamura
Journal:  Biomaterials       Date:  2000-05       Impact factor: 12.479

4.  Nanoconjugate based on polymalic acid for tumor targeting.

Authors:  Julia Y Ljubimova; Manabu Fujita; Natalya M Khazenzon; Bong-Seop Lee; Sebastian Wachsmann-Hogiu; Daniel L Farkas; Keith L Black; Eggehard Holler
Journal:  Chem Biol Interact       Date:  2007-02-08       Impact factor: 5.192

5.  New functional degradable and bio-compatible nanoparticles based on poly(malic acid) derivatives for site-specific anti-cancer drug delivery.

Authors:  Zhi Wei Huang; Véronique Laurent; Ghizlane Chetouani; Julia Y Ljubimova; Eggehard Holler; Thierry Benvegnu; Pascal Loyer; Sandrine Cammas-Marion
Journal:  Int J Pharm       Date:  2011-04-27       Impact factor: 5.875

6.  Antitumor imidazotetrazines. 41. Conjugation of the antitumor agents mitozolomide and temozolomide to peptides and lexitropsins bearing DNA major and minor groove-binding structural motifs.

Authors:  Jill Arrowsmith; Sharon A Jennings; Alan S Clark; Malcolm F G Stevens
Journal:  J Med Chem       Date:  2002-12-05       Impact factor: 7.446

7.  Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-L-malic acid) for drug delivery.

Authors:  Bong-Seop Lee; Manabu Fujita; Natalya M Khazenzon; Kolja A Wawrowsky; Sebastian Wachsmann-Hogiu; Daniel L Farkas; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

8.  Biodegradable nanoparticles of partially methylated fungal poly(beta-L-malic acid) as a novel protein delivery carrier.

Authors:  José A Portilla-Arias; Montserrat García-Alvarez; Juan A Galbis; Sebastián Muñoz-Guerra
Journal:  Macromol Biosci       Date:  2008-06-11       Impact factor: 4.979

9.  Investigation of the degradation mechanisms of poly(malic acid) esters in vitro and their related cytotoxicities on J774 macrophages.

Authors:  Maria Elisa Martinez Barbosa; Sandrine Cammas; Martine Appel; Gilles Ponchel
Journal:  Biomacromolecules       Date:  2004 Jan-Feb       Impact factor: 6.988

Review 10.  Nanoparticles for drug delivery in cancer treatment.

Authors:  Barbara Haley; Eugene Frenkel
Journal:  Urol Oncol       Date:  2008 Jan-Feb       Impact factor: 3.498

View more
  4 in total

1.  Nanoparticles of esterified polymalic acid for controlled anticancer drug release.

Authors:  Alberto Lanz-Landázuri; José Portilla-Arias; Antxon Martínez de Ilarduya; Montserrat García-Alvarez; Eggehard Holler; Julia Ljubimova; Sebastián Muñoz-Guerra
Journal:  Macromol Biosci       Date:  2014-06-06       Impact factor: 4.979

2.  The effect of Tween 80 on the polymalic acid and pullulan production by Aureobasidium pullulans CCTCC M2012223.

Authors:  Guangwei Tu; Yongkang Wang; Yunchao Ji; Xiang Zou
Journal:  World J Microbiol Biotechnol       Date:  2014-11-21       Impact factor: 3.312

Review 3.  Biosynthetic Polymalic Acid as a Delivery Nanoplatform for Translational Cancer Medicine.

Authors:  Jianguo Zhang; Deyu Chen; Guoxin Liang; Wenrong Xu; Zhimin Tao
Journal:  Trends Biochem Sci       Date:  2020-10-22       Impact factor: 13.807

4.  Preparation of Temozolomide-Loaded Nanoparticles for Glioblastoma Multiforme Targeting-Ideal Versus Reality.

Authors:  Chooi Yeng Lee; Ing Hong Ooi
Journal:  Pharmaceuticals (Basel)       Date:  2016-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.